Sosei Group Corporation

PINK:SOLTF USA Biotechnology
Market Cap
$534.82 Million
Market Cap Rank
#10976 Global
#4988 in USA
Share Price
$5.91
Change (1 day)
+0.00%
52-Week Range
$5.91 - $5.91
All Time High
$59.26
About

Nxera Pharma Co., Ltd. operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally. The company offers NxWave, a GPCR-targeted structure-based drug discovery platform; PIVLAZ for the cerebral vasospasm, vasospasm-related cerebral infarction, and cerebral ischemic symptoms aft… Read more

Sosei Group Corporation (SOLTF) - Total Liabilities

Latest total liabilities as of September 2025: $79.64 Billion USD

Based on the latest financial reports, Sosei Group Corporation (SOLTF) has total liabilities worth $79.64 Billion USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Sosei Group Corporation - Total Liabilities Trend (2004–2024)

This chart illustrates how Sosei Group Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Sosei Group Corporation Competitors by Total Liabilities

The table below lists competitors of Sosei Group Corporation ranked by their total liabilities.

Liability Composition Analysis (2004–2024)

This chart breaks down Sosei Group Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.14 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.20 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.54 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sosei Group Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sosei Group Corporation (2004–2024)

The table below shows the annual total liabilities of Sosei Group Corporation from 2004 to 2024.

Year Total Liabilities Change
2024-12-31 $82.98 Billion -8.20%
2023-12-31 $90.39 Billion +117.90%
2022-12-31 $41.48 Billion +4.97%
2021-12-31 $39.52 Billion +64.08%
2020-12-31 $24.08 Billion +107.58%
2019-12-31 $11.60 Billion -43.68%
2018-12-31 $20.60 Billion 0.00%
2017-12-31 $20.60 Billion +7.06%
2016-12-31 $19.24 Billion -20.11%
2015-12-31 $24.09 Billion -16.68%
2014-12-31 $28.91 Billion +12618.20%
2013-12-31 $227.28 Million -19.68%
2012-12-31 $282.96 Million -1.79%
2011-12-31 $288.11 Million -14.08%
2010-12-31 $335.34 Million +61.50%
2009-12-31 $207.64 Million +30.57%
2008-12-31 $159.03 Million -74.96%
2007-12-31 $635.06 Million -66.77%
2006-12-31 $1.91 Billion +129.93%
2005-12-31 $831.25 Million +442.14%
2004-12-31 $153.33 Million --